蔣澄宇，1964年生，生物化學與分子生物學家，中國醫學科學院基礎醫學研究所研究員，博士生導師。1988年畢業于中國科學技術大學生物系，獲理學學士學位；1996年畢業于美國布朗大學醫學院病理與實驗室藥學系，獲博士學位。隨后于哈佛醫學院麻省總醫院從事博士后工作。 2003年至今，中國醫學科學院基礎醫學研究所教授。

致力于植物藥新主流有效成分小RNA的藥效和遞送系統研發，以及病毒等引起的呼吸衰竭的機制和治療研究，發現ARB類藥物對SARS、禽流感、微納米顆粒及SARS-CoV-2感染引發的重癥肺炎及多器官衰竭有很好的治療效果并顯著降低了治療組死亡率。

爆草黑丝美女|韩国19禁无遮挡啪啪无码网站|91精品国产自产精品男人的天堂|sm鞭打高潮喷水抽搐调教玩弄

1. Zhao Y#, Huang F#, Zou Z#, Bi Y#, Yang Y#, Zhang C, Liu Q, Shang D, Yan Y, Ju X, Mei S, Xie P, Li X, Tian M, Tan S, Lu H, Han Z, Liu K, Zhang Y, Liang J, Liang Z, Zhang Q, Chang J, Liu WJ, Feng C, Li T, Zhang MQ, Wang X, Gao GF, Liu Y*, Jin N*, Jiang C*. Avian influenza viruses suppress innate immunity by inducing trans-transcriptional readthrough via SSU72. Cell Mol Immunol, 2022. 19(6):702-714. (IF=22.096)

2. Liu Y#, Zhang C#, Huang F#, Yang Y#, Wang F, Yuan J, Zhang Z, Qin Y, Li X, Zhao D, Li S, Tan S, Wang Z, Li J, Shen C, Li J, Peng L, Wu W, Cao M, Xing L, Xu Z, Chen L, Zhou C, Liu WJ*, Liu L*, Jiang C*. Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury. Natl Sci Rev, 2020.7(6):1003-1011. (IF=23.178, C100, ESI)

3. Liu Y#*, Yang Y#, Zhang C#, Huang F#, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, Zhang Z, Wang L, Peng L, Chen L, Qin Y, Zhao D, Tan S, Yin L, Xu J, Zhou C, Jiang C*, Liu L*. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci, 2020. 63(3):364-374. (IF=10.372, C100, ESI)

4. Yan F#, Huang F#, Xu J#, Yang P#, Qin Y#, Lv J#, Zhang S, Ye L, Gong M, Liu Z, Wei J, Xie T, Xu KF, Gao GF, Wang FS, Cai L*, Jiang C*. Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients. Cell Discov, 2020. 6(1):77. (IF=38.079)

5. Yang Y#, Shen C#, Li J#, Yuan J, Wei J, Huang F, Wang F, Li G, Li Y, Xing L, Peng L, Yang M, Cao M, Zheng H, Wu W, Zou R, Li D, Xu Z, Wang H, Zhang M, Zhang Z, Gao GF, Jiang C*, Liu L*, Liu Y*. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol, 2020. 146(1):119-127.e4. (IF=14.290, C100, ESI)

6. Li X#, Liang Z#, Du J#, Wang Z#, Mei S, Li Z, Zhao Y, Zhao D, Ma Y, Ye J, Xu J, Zhao Y, Chang J, Qin Y, Yu L, Wang C*, Jiang C*. Herbal decoctosome is a novel form of medicine. Sci China Life Sci, 2019. 62(3):333-348. (IF=10.372)

7. Huang F#, Du J#, Liang Z#, Xu Z, Xu J, Zhao Y, Lin Y, Mei S, He Q, Zhu J, Liu Q, Zhang Y, Qin Y, Sun W, Song J, Chen S, Jiang C*. Large-scale analysis of small RNAs derived from traditional Chinese herbs in human tissues. Sci China Life Sci, 2019. 62(3):321-332. (IF=10.372)

8. Zou Z#, Yan Y#, Shu Y#, Gao R#, Sun Y, Li X, Ju X, Liang Z, Liu Q, Zhao Y, Guo F, Bai T, Han Z, Zhu J, Zhou H, Huang F, Li C, Lu H, Li N, Li D, Jin N*, Penninger JM*, Jiang C*. Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat Commun, 2014. 6(5):3594. (IF=17.694, C100, ESI)

9. Wang H#, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C*. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res, 2008.18(2):290-301. (IF=46.297, C100)

10. Kuba K#, Imai Y#, Rao S#, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C*, Penninger JM. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med, 2005. 11(8):875-9. (IF=87.241, C100)